Cargando…
MGMT Promoter Methylation as a Prognostic Factor in Primary Glioblastoma: A Single-Institution Observational Study
Glioblastoma is the most malignant central nervous system tumor, which represents 50% of all glial tumors. The understanding of glioma genesis, prognostic evaluation, and treatment planning has been significantly enhanced by the discovery of molecular genetic biomarkers. This study aimed to evaluate...
Autores principales: | Szylberg, Mateusz, Sokal, Paweł, Śledzińska, Paulina, Bebyn, Marek, Krajewski, Stanisław, Szylberg, Łukasz, Szylberg, Aneta, Szylberg, Tadeusz, Krystkiewicz, Kamil, Birski, Marcin, Harat, Marek, Włodarski, Robert, Furtak, Jacek |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405779/ https://www.ncbi.nlm.nih.gov/pubmed/36009577 http://dx.doi.org/10.3390/biomedicines10082030 |
Ejemplares similares
-
Infratentorial Stereotactic Biopsy of Brainstem and Cerebellar Lesions
por: Furtak, Jacek, et al.
Publicado: (2021) -
Endoscopic versus stereotactic biopsies of intracranial lesions involving the ventricles
por: Birski, Marcin, et al.
Publicado: (2020) -
Correction to: Endoscopic versus stereotactic biopsies of intracranial lesions involving the ventricles
por: Birski, Marcin, et al.
Publicado: (2021) -
Glioma Biopsy Based on Hybrid Dual Time-Point FET-PET/MRI—A Proof of Concept Study
por: Furtak, Jacek, et al.
Publicado: (2021) -
Combining amino acid PET and MRI imaging increases accuracy to define malignant areas in adult glioma
por: Harat, Maciej, et al.
Publicado: (2023)